Gut bacteria and immunity in people with an abnormal blood protein
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy, Infections clinical trials.
This study looks at how your gut bacteria (intestinal flora) and immune system relate to a condition called monoclonal gammopathy, where an abnormal protein is found in the blood. The trial will check samples from your blood, plasma, and stool to understand these connections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years or older.
- Your blood test showed no abnormal monoclonal protein (monoclonal gammaglobulin).
- You have no signs of infection (normal blood tests for infection).
- You have not taken antibiotics in the past month.
- You have no history of bowel tumors, irritable bowel syndrome, or inflammatory bowel disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the gut bacteria of healthy adults (age 45+) with those who have a blood condition called monoclonal gammopathy. The goal is to see if gut bacteria patterns differ between the two groups.
This study looks at stored blood (serum) samples to see whether a lab test called MALDI-TOF mass spectrometry can help analyze multiple myeloma proteins. If you have multiple myeloma (or are a healthy matched control), your existing lab samples may be used for testing.
This study screens healthy adults for a protein in the blood called M protein, which can be an early sign of certain blood conditions. It aims to catch these conditions early and monitor those with positive results.
This study looks at blood cells from people with certain blood conditions who also have fevers with no clear cause. It aims to understand the genetic and functional features of these cells, which may help explain why fever and inflammation happen. You will likely have a blood sample taken for testing, and the results may inform future treatments, though the study itself does not test a new treatment.
This study is collecting blood samples from people with plasma cell disorders to help researchers learn more about these conditions. It may be a good fit if you haven't started treatment yet and are willing to donate samples.
This research study looks at how certain sugar molecules (N-glycosylation) on proteins may play a role in a disease called AL amyloidosis. Researchers will study blood samples from people with related plasma cell disorders to learn more about these sugars, which could help with diagnosis and treatment.
Hear when a new Multiple myeloma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.